Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Synthesis of GD3-lactam: a potential ligand for the development of an anti-melanoma vaccine.

Hossain, Nafizal ; Zapata, Amparo ; Wilstermann, Mikael ; Nilsson, Ulf LU and Magnusson, Göran (2002) In Carbohydrate Research 337(7). p.569-580
Abstract
The novel sialyl donor methyl (ethyl 4,7,8,9-tetra-O-acetyl-5-N,N-diacetylamino-3,5-dideoxy-2-thio-3-thiophenyl-D-erythro-beta-L-gluco-non-2-ulopyranosid)onate was used for glycosylation of a lactosyl acceptor to give the GM3-trisaccharide derivative in 83% yield. Introduction of an azido group at C-9" of the GM3-trisaccharide derivative, transformation into a glycosyl acceptor, and sialylation with the above mentioned novel sialyl donor gave a GD3-trisaccharide in 50% yield. Reduction of the azido group gave the corresponding amine, which underwent spontaneous lactamization to the GD3-[1"'-9"]-lactam in an overall yield of 86%. Removal of protecting groups of over five steps, followed by per-O-acetylation gave an acetylated... (More)
The novel sialyl donor methyl (ethyl 4,7,8,9-tetra-O-acetyl-5-N,N-diacetylamino-3,5-dideoxy-2-thio-3-thiophenyl-D-erythro-beta-L-gluco-non-2-ulopyranosid)onate was used for glycosylation of a lactosyl acceptor to give the GM3-trisaccharide derivative in 83% yield. Introduction of an azido group at C-9" of the GM3-trisaccharide derivative, transformation into a glycosyl acceptor, and sialylation with the above mentioned novel sialyl donor gave a GD3-trisaccharide in 50% yield. Reduction of the azido group gave the corresponding amine, which underwent spontaneous lactamization to the GD3-[1"'-9"]-lactam in an overall yield of 86%. Removal of protecting groups of over five steps, followed by per-O-acetylation gave an acetylated GD3-[1"'-9"]-lactam TMSEt glycoside in 27% overall yield. The acetylated GD3-[1"'-9"]-lactam TMSEt glycoside is suitable for glycosylation of linker-arms and the resulting linker-glycosides are planned to be coupled to carrier proteins, thus providing immunogens for trial vaccinations against malignant melanoma. (Less)
Please use this url to cite or link to this publication:
author
; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Melanoma, Antigen, GD3, GD3-lactam, Glycosylation
in
Carbohydrate Research
volume
337
issue
7
pages
569 - 580
publisher
Elsevier
external identifiers
  • wos:000174862500001
  • pmid:11909589
  • scopus:0036129329
ISSN
1873-426X
DOI
10.1016/S0008-6215(02)00036-8
language
English
LU publication?
yes
additional info
The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Organic chemistry (S/LTH) (011001240)
id
e64f8053-1cca-43e7-ad36-7d374a706d57 (old id 105840)
date added to LUP
2016-04-01 11:33:33
date last changed
2022-01-26 07:03:39
@article{e64f8053-1cca-43e7-ad36-7d374a706d57,
  abstract     = {{The novel sialyl donor methyl (ethyl 4,7,8,9-tetra-O-acetyl-5-N,N-diacetylamino-3,5-dideoxy-2-thio-3-thiophenyl-D-erythro-beta-L-gluco-non-2-ulopyranosid)onate was used for glycosylation of a lactosyl acceptor to give the GM3-trisaccharide derivative in 83% yield. Introduction of an azido group at C-9" of the GM3-trisaccharide derivative, transformation into a glycosyl acceptor, and sialylation with the above mentioned novel sialyl donor gave a GD3-trisaccharide in 50% yield. Reduction of the azido group gave the corresponding amine, which underwent spontaneous lactamization to the GD3-[1"'-9"]-lactam in an overall yield of 86%. Removal of protecting groups of over five steps, followed by per-O-acetylation gave an acetylated GD3-[1"'-9"]-lactam TMSEt glycoside in 27% overall yield. The acetylated GD3-[1"'-9"]-lactam TMSEt glycoside is suitable for glycosylation of linker-arms and the resulting linker-glycosides are planned to be coupled to carrier proteins, thus providing immunogens for trial vaccinations against malignant melanoma.}},
  author       = {{Hossain, Nafizal and Zapata, Amparo and Wilstermann, Mikael and Nilsson, Ulf and Magnusson, Göran}},
  issn         = {{1873-426X}},
  keywords     = {{Melanoma; Antigen; GD3; GD3-lactam; Glycosylation}},
  language     = {{eng}},
  number       = {{7}},
  pages        = {{569--580}},
  publisher    = {{Elsevier}},
  series       = {{Carbohydrate Research}},
  title        = {{Synthesis of GD3-lactam: a potential ligand for the development of an anti-melanoma vaccine.}},
  url          = {{http://dx.doi.org/10.1016/S0008-6215(02)00036-8}},
  doi          = {{10.1016/S0008-6215(02)00036-8}},
  volume       = {{337}},
  year         = {{2002}},
}